Home Categories Clidinium bromide
A2453612

Clidinium bromide , Analysis standard , 3485-62-9

Synonym(s):
3-[(Hydroxydiphenylacetyl)oxy]-1-methyl-1-azoniabicyclo[2.2.2]octane bromide;3-Hydroxy-1-methylquinuclidinium bromide benzilate

CAS NO.:3485-62-9

Empirical Formula: C22H26BrNO3

Molecular Weight: 432.35

MDL number: MFCD00078996

EINECS: 222-471-3

Pack Size Price Stock Quantity
1G RMB637.60 In Stock
others     Enquire
Update time: 2022-07-08

PRODUCT Properties

Melting point: 240-241°C
storage temp.  Inert atmosphere,Room Temperature
solubility  DMSO (Slightly), Methanol (Slightly, Sonicated), Water (Slightly)
form  Solid
color  White to Off-White
Major Application forensics and toxicology
pharmaceutical (small molecule)
veterinary
InChI 1S/C22H26NO3.BrH/c1-23-14-12-17(13-15-23)20(16-23)26-21(24)22(25,18-8-4-2-5-9-18)19-10-6-3-7-11-19;/h2-11,17,20,25H,12-16H2,1H3;1H
InChIKey WVDSMJSQJXGCNY-UHFFFAOYSA-N
SMILES Br.C[N]12CCC(CC1)C(C2)OC(=O)C(O)(c3ccccc3)c4ccccc4
CAS DataBase Reference 3485-62-9(CAS DataBase Reference)

Description and Uses

Clidinium is a gastrointestinal muscarinic receptor antagonist (Ki = 3 nM against [3H]quinuclidinyl benzilate binding in rat colonic enterocytes). Administration of clidinium, at a dose of 1 mg/kg, slows intestinal transit and induces constipation in mice. This clidinium-induced constipation induces serum hyperammonemia and decreases clonic, myoclonic, and tonic seizure thresholds in a murine pentylenetetrazole-induced epilepsy model.

An anticholinergic. Used as an antispasmodic.

Safety

Symbol(GHS) 
GHS07
Signal word  Warning
Hazard statements  H302
Precautionary statements  P264-P270-P301+P312-P501
PPE dust mask type N95 (US), Eyeshields, Faceshields, Gloves
Hazard Codes  Xn
Risk Statements  22
Safety Statements  36
RIDADR  3249
WGK Germany  3
RTECS  VD6125000
HazardClass  6.1(b)
PackingGroup  III
HS Code  2933399090
Storage Class 11 - Combustible Solids
Hazard Classifications Acute Tox. 4 Oral

RELATED PRODUCTS